Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1751 - 1775 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Ustekinumab	cdr_SR0359_Stelara.pdf cdr_complete_SR0359_Stelara_Oct-22-14.pdf SR0359_Stelara_PE_Report.pdf SR0359_Stelara_CL_Report.pdf SR0359_Stelara_PI_Submissions.pdf	Oct 30, 2013	Reimbursement Review	Complete	SR0359-000
Fluticasone furoate /vilanterol	cdr_SR0358_Breo_Ellipta.pdf cdr_complete_breo_ellipta_august_20_2014.pdf SR0358_BreoEllipta_PE_Report.pdf SR0358_BreoEllipta_CL_Report.pdf	Oct 29, 2013	Reimbursement Review	Complete	SR0358-000
Dolutegravir	cdr_SR0357_Tivicay.pdf cdr_complete_tivicay_august_20_2014.pdf sr0357_tivicay_cl_report.pdf sr0357_tivicay_pe_report.pdf	Oct 18, 2013	Reimbursement Review	Complete	SR0357-000
Alemtuzumab	cdr_SR0355_Lemtrada.pdf	Oct 1, 2013	Reimbursement Review	Withdrawn	SR0355-000
Aripiprazole	cdr_SR0354_Abilify.pdf SR0354_AbilifyMDD_CL_Report_e.pdf SR0354_AbilifyMDD_PE_Report.pdf cdr_complete_SR0354_Abilify-MDD_Oct-24_2014.pdf	Oct 1, 2013	Reimbursement Review	Complete	SR0354-000
Sofosbuvir	cdr_SR0356_TBC_(Sofosbuvir).pdf SR0356_Sovaldi_CL_Report_e.pdf SR0356_Sovaldi_PE_Report_e.pdf cdr_complete_sovaldi_august_20_2014.pdf	Oct 1, 2013	Reimbursement Review	Complete	SR0356-000
Phleum pratense	cdr_SR0352_Grastek.pdf SR0352_Grastek_CL_Report_e.pdf SR0352_Grastek_PE_Report_e.pdf cdr_complete_SR0352_Grastek_sep-26_14.pdf	Sep 30, 2013	Reimbursement Review	Complete	SR0352-000
Riociguat	cdr_SR0353_Adempas.pdf SR0353_complete_Adempas_Jul-21-14.pdf SR0353_Adempas_CL_Report_e.pdf SR0353_Adempas_PE_Report-e.pdf	Sep 30, 2013	Reimbursement Review	Complete	SR0353-000
Adcetris for Hodgkin Lymphoma - Details	pcodr-provfund_adcetris-hl.pdf pcodr-adcetrishl-fn-rec.pdf pcodr-adcetrishl-fn-cgr.pdf pcodr-adcetrishl-fn-egr.pdf pcodr-adcetrishl-in-rec.pdf pcodr-adcetrishl-pag-fdk-inrec.pdf pcodr-adcetrishl-in-fdk-sg.pdf pcodr-adcetrishl-pt-fdk-lfc.pdf pcodr-adcetrishl-coi-lfc.pdf	Sep 17, 2013	Reimbursement Review	Complete	PC0020-000
Votrient for metastatic renal cell carcinoma - Resubmission - Details	pcodr-provfund_votrientmrcc-re.pdf pcodr-votrientmrccre-fn-rec.pdf pcodr-votrientmrccre-fn-cgr.pdf pcodr-votrientmrccre-fn-egr.pdf pcodr-votrientmrccre-in-rec.pdf pcodr-votrientmrccre-pag-fdbk.pdf pcodr-votrientmrccre-infdk-gsk.pdf pcodr-votrientmrccre-ptfdk-kcc.pdf pcodr-votrientmrccre-coi-kcc.pdf	Sep 17, 2013	Reimbursement Review	Complete	PC0022-000
Golimumab	cdr_SR0351_Simponi-IV.pdf SR0351_complete_Simponi_IV_Jul-21-14.pdf SR0351_SimponiIV_CL_Report.pdf SR0351_SimponiIV_PE_Report.pdf	Sep 12, 2013	Reimbursement Review	Complete	SR0351-000
Teriflunomide	cdr_SR0350_Aubagio.pdf SR0350_Aubagio_CL_Report_e.pdf SR0350_Aubagio_PE_Report_e.pdf SR0350_complete_Aubagio_Jun-19-14.pdf	Aug 28, 2013	Reimbursement Review	Complete	SR0350-000
Guanfacine hydrochloride	cdr_SR0349_Intuniv-XR.pdf cdr_complete_SR0349_Intuniv-XR_sep-26_14.pdf SR0349_IntunivXR_CL_Report_e.pdf SR0349_IntunivXR_PE_Report_e.pdf	Aug 27, 2013	Reimbursement Review	Complete	SR0349-000
Simeprevir	cdr_SR0347_TBC.pdf SR0347_complete_Galexos-Jun-20-14.pdf SR0347_Galexos_CL_Report.pdf SR0347_Galexos_PE_Report.pdf	Aug 22, 2013	Reimbursement Review	Complete	SR0347-000
Aclidinium bromide	cdr_SR0346_Tudorza_Genuair.pdf SR0346_TudorzaGenuair_CL_Report.pdf SR0346_TudorzaGenuair_PE_Report.pdf cdr_complete_SR0346_Tudorza Genuair_Ap_23_2014.pdf	Aug 21, 2013	Reimbursement Review	Complete	SR0346-000
Perjeta for Metastatic Breast Cancer – Details	pcodr_profund_pertuzumab_perjeta_mbc.pdf pcodr-perjetacp-mbc-fn-rec.pdf pcodr-perjetacp-mbc-fn-cgr.pdf pcodr-perjetacp-mbc-fn-egr.pdf pcodr-perjetacp-mbc-in-rec.pdf pcodr-perjetacp-pag-fdk-in-rec.pdf pcodr-perjetacp-mbc-in-fdk-hlr.pdf pcodr-perjetacp-mbc-coi-cbcn.pdf pcodr-perjetacp-mbc-coi-rethin.pdf	Aug 20, 2013	Reimbursement Review	Complete	PC0018-000
OnabotulinumtoxinA	cdr_SR0345_Botox-Migraine.pdf SR0345_complete_Botox-May-30-14.pdf SR0345_Botox_Migraine_CL_Report_e.pdf SR0345_Botox_Migraine_PE_Report_e.pdf	Aug 15, 2013	Reimbursement Review	Complete	SR0345-000
Xtandi for metastatic Castration Resistant Prostate Cancer - Details	pcodr_profund_enzalutamide_xtandi_mcrpc.pdf pcodr-xtandi-fn-rec.pdf pcodr-xtandi-mcrpc-fn-cgr.pdf pcodr-xtandi-mcrpc-fn-egr.pdf pcodr-xtandi-mcrpc-in-rec.pdf pcodr-xtandi-pag-fdk-in-rec.pdf pcodr-xtandi-in-fdk-astellas.pdf pcodr-xtandi-coi-pcc.pdf pcodr-xtandi-coi-ccsn.pdf	Aug 8, 2013	Reimbursement Review	Complete	PC0023-000
Rotigotine	cdr_SR0344_Neupro.pdf SR0344_Neupro_CL_Report.pdf SR0344_Neupro_PE_Report.pdf SR0344_complete_Neupro_May-30-14.pdf	Jul 31, 2013	Reimbursement Review	Complete	SR0344-000
Tocilizumab	cdr_SR0343_Actemra-pJIA.pdf SR0343_Actemra pJIA_CL_Report_e.pdf SR0343_Actemra pJIA_PE_Report_e.pdf cdr_complete_Actemra_Mar_24_14_e.pdf	Jul 29, 2013	Reimbursement Review	Complete	SR0343-000
Tykerb Letrozole for Metastatic Breast Cancer - Details	pcodr-provfund_tykerb-mbc.pdf pcodr-tykerb-mbc-fn-rec.pdf pcodr-tykerb-mbc-fn-cgr.pdf pcodr-tykerb-mbc-fn-egr.pdf pcodr-tykerb-mbc-in-rec.pdf pcodr-tykerbmbc-pag-fdk-in-rec.pdf pcodr-tykerbmbc-in-fdk-gsk.pdf	Jul 22, 2013	Reimbursement Review	Complete	PC0019-000
Golimumab	cdr_SR0341 Simponi UC.pdf SR0341_Simponi_CL_Report_e.pdf SR0341_Simponi_PE_Report_e.pdf SR0341_complete_Simponi_Mar-28-14.pdf	Jul 12, 2013	Reimbursement Review	Complete	SR0341-000
Eplerenone	cdr_SR0342 Inspra HF.pdf SR0342_InspraHF_CL_Report_e.pdf SR0342_Inspra HF_PE_Report_e.pdf cdr_complete_SR0342_Inspra_Apr-28_14.pdf	Jul 12, 2013	Reimbursement Review	Complete	SR0342-000
Xalkori for Advanced NSCLC - Resubmission - Details	pcodr-provfund_xalkorire-nsclc.pdf pcodr-xalkoriresub-fn-rec.pdf pcodr-xalkoriresub-fn-cgr.pdf pcodr-xalkoriresub-fn-egr.pdf pcodr-xalkoriresub-in-rec.pdf pcodr-xalkorire-pag-fdk-in-rec.pdf pcodr-xalkoriresub-fdk-pfizer.pdf pcodr-xalkorire-fdk-lcc.pdf pcodr-xalkoriresub-coi-lcc.pdf	Jun 17, 2013	Reimbursement Review	Complete	PC0017-000
Ocriplasmin	cdr_SR0337_Jetrea.pdf SR0337_Jetrea_CL_Report_e.pdf SR0337_Jetrea_PE_Report_e.pdf SR0337_complete_Jetrea_Dec-23-13.pdf	Jun 6, 2013	Reimbursement Review	Complete	SR0337-000